
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Prealbumin CRISPR/Cas9 KO Plasmid (h) | sc-401083 | 20 µg | $397.00 |
Human TTR encodes prealbumin (transthyretin), a secreted tetrameric carrier protein that transports thyroxine (T4) and retinol via binding to retinol-binding protein, supporting endocrine hormone distribution and vitamin A homeostasis. Prealbumin is synthesized predominantly by hepatocytes and also expressed in the choroid plexus, contributing to protein and hormone trafficking across plasma and cerebrospinal fluid compartments. Its biology intersects with secretory pathway proteostasis, extracellular protein turnover, and ligand-binding dynamics that influence systemic metabolic signaling. Dysregulated TTR folding and aggregation are linked to amyloid deposition disorders, while altered expression or stability can inform studies of liver function, thyroid hormone handling, and protein misfolding mechanisms.
Prealbumin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TTR gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TTR together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TTR open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Prealbumin protein expression.
This CRISPR knockout system enables efficient generation of TTR-deficient cell models for investigation of Prealbumin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.